Protein-protein interactions

by Wendt, Michael D.

Type Book

Rate 0.0 /5

Details

Files

Reviews

Download

Title Statements

Full title :Protein-protein interactions / edited by Michael D. Wendt.

Summary

Michael D. WendtProtein-Protein Interactions as Drug TargetsShaomeng Wang, Yujun Zhao, Denzil Bernard, Angelo Aguilar, Sanjeev KumarTargeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes, Jeremy Murray, Domagoj VucicThe Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow, David R. Langley, Nicholas A. Meanwell, Michael A. Walker, Kap-Sun Yeung, Richard PracittoProtein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell, David R. LangleyInhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial Virus Andrew B. Mahon, Stephen E. Miller, Stephen T. Joy, Paramjit S. AroraRational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. WendtThe Discovery of Navitoclax, a Bcl-2 Family Inhibitor.

Edition Statements

Publication Date:2012.

Publication Statements

Publisher(s):Springer
Place of Publication:Berlin
Language:eng
Publication Date:2012.

Notes

Titre de l'écran-titre (visionné le 24 août 2012).

The Physical Object

Description:1 online resource (1 texte électronique)

Edition Identifiers

ISBN:3642289657, 9783642289651
oclc:ocn822590902
LC Classification:QP551.5
Dewey Decimal:572.64

Protein-Protein Interactions as Drug Targets -- Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics -- The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer -- Protein-Protein Interaction Targets to Inhibit HIV-1 Infection -- Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion -- a Focus on Respiratory Syncytial Virus -- Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces -- The Discovery of Navitoclax, a Bcl-2 Family Inhibitor.